Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps3-13-120 | Pregnancy & Iodine | ETA2022

The impact of thyroid function on neonatal outcome in women with polycystic ovary syndrome treated with metformin or placebo during pregnancy

Trouva Anastasia , Alvarsson Michael , Calissendorff Jan , Olav AEsvold Bjorn , Linden Hirschberg Angelica , Vanky Eszter

Objectives: Polycystic ovary syndrome (PCOS) and thyroid disorders have separately been linked to adverse pregnancy and neonatal outcomes. Even small variations in thyroid function within the normal range may influence fetal growth. Previous data have shown that metformin-treatment of pregnant women with PCOS reduced late miscarriages and preterm births, and resulted in less decrease of fT4 compared to placebo. Moreover, metformin exposure in utero altered the offspring anthro...

ea0099p460 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Polycystic ovary syndrome in type 1 diabetes mellitus: a cross-sectional study of 785 women with diabetes and 1152 controls

Toft Sofia , Rajamand Ekberg Neda , Abdulrahim Hidaya , Linden Hirschberg Angelica , Alvarsson Michael

Background: The prevalence of reproductive disturbances in women with Type 1 Diabetes Mellitus (T1DM) is high compared to the general population. One reason might be higher prevalence of Polycystic ovary syndrome (PCOS) in T1DM. In Sweden, with a high incidence of T1DM, the prevalence of PCOS in women with T1DM is not known. Neither is the T1DM-PCOS pathophysiology.Aim: The aim of this cross-sectional study was to investigate the prevalence of PCOS in a ...